Product Information
GLIPIZIDE ER 2.5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1012 per EA under NDC 64980027903. Its NADAC has been published 472 times since Aug 9, 2017.
FDA first approved this application on Dec 29, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980027903
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
GLIPIZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204720FDA Approved
12/29/2016
TE Code
AB
On Market Since
4/24/2017
Pharmacological Classes
Price Statistics
The NADAC for GLIPIZIDE ER 2.5 MG TABLET has been published 472 times since Aug 9, 2017, and over the history we have for it it has declined 48.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1012 per EA |
|---|---|
| All-time high | $0.1955 (Aug 16, 2017) |
| All-time low | $0.0974 (Nov 20, 2024) |
| 52-week high | $0.1102 |
| 52-week low | $0.1012 |
| Median price | $0.1414 |
| Average price | $0.1389 |
| Largest weekly change | -20.0% (Nov 20, 2024) |
| Weeks tracked | 472 |
| Tracking since | Aug 9, 2017 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GLIPIZIDE ER 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLIPIZIDE ER 2.5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1012 per EA (NDC 64980027903), effective Aug 19, 2026.
How has the price of GLIPIZIDE ER 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLIPIZIDE ER 2.5 MG TABLET has declined 48.3%. It has been tracked across 472 weekly CMS publications since Aug 9, 2017.
What are the highest and lowest recorded NADAC prices for GLIPIZIDE ER 2.5 MG TABLET?
Since Aug 9, 2017, the NADAC for GLIPIZIDE ER 2.5 MG TABLET has ranged from a low of $0.0974 (Nov 20, 2024) to a high of $0.1955 (Aug 16, 2017), with a median of $0.1414 per EA.
Are there cheaper alternatives to GLIPIZIDE ER 2.5 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GLIPIZIDE ER 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures GLIPIZIDE ER 2.5 MG TABLET?
GLIPIZIDE ER 2.5 MG TABLET (NDC 64980027903) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.